Computer-extracted tumour characteristics have been incorporated into medical imaging
computer-aided diagnosis (CAD) algorithms for decades. With the advent of radiomics, an …

Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs
used daily in oncology include clinical TNM stage, objective response and left ventricular …

Tumors exhibit genomic and phenotypic heterogeneity, which has prognostic significance
and may influence response to therapy. Imaging can quantify the spatial variation in …

Purpose: To present a review of most commonly used techniques to analyze dynamic
contrast‐enhanced magnetic resonance imaging (DCE‐MRI), discusses their strengths and …

In countries with the best cancer outcomes, approximately 60% of patients receive
radiotherapy as part of their treatment, which is one of the most cost-effective cancer …

There is increasing recognition of the importance of blood–brain barrier (BBB) disruption in
aging, dementia, stroke and multiple sclerosis in addition to more commonly-studied …

Radiation therapy (RT) is an essential component of effective cancer care and is used
across nearly all cancer types. The delivery of RT is becoming more precise through rapid …

Eribulin mesylate is a synthetic macrocyclic ketone analog of the marine sponge natural
product halichondrin B and an inhibitor of microtubule dynamics. Some tubulin‐binding …

Ferroptosis has been realized in anticancer drug–induced acute cardiac/kidney injuries
(ACI/AKI); however, molecular imaging approach to detect ferroptosis in ACI/AKI is a …

Bevacizumab is the first antiangiogenic therapy proven to slow metastatic disease
progression in patients with cancer. Although it has changed clinical practice, some patients …